Workflow
JBDI Holdings Regains Compliance with Nasdaq's Minimum Bid Price Requirement
GlobeNewswire News Room· 2025-06-06 13:15
Core Points - JBDI Holdings Limited has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1) as of June 3, 2025, after previously failing to maintain a minimum bid price of $1.00 for 30 consecutive business days [1][2] - The company received a deficiency notice from Nasdaq on June 3, 2025, for not filing its interim balance sheet and income statement for the second quarter, thus violating Listing Rule 5250(c)(2) [4] - JBDI Holdings filed its unaudited condensed consolidated financial statements for the six-month periods ended November 30, 2024, and 2023 on June 5, 2025, and intends to notify Nasdaq of this filing to regain compliance with the listing rule [5] Company Overview - JBDI Holdings Limited specializes in environmentally friendly and efficient products and services, focusing on the revitalization, reconditioning, and recycling of drums and related containers in Singapore and Southeast Asia [7] - The company has nearly four decades of industry experience and is recognized for quality and reliability, offering a range of reconditioned steel and plastic drums, new containers, and ancillary services [7] - JBDI's mission is to help customers achieve a zero environmental impact footprint while optimizing resource allocation and reducing costs [7]
Fitzroy Minerals Reports 110 m @ 1.94% Cu, Including 58 m @ 3.06% Cu at the Buen Retiro Copper Project, Chile
Thenewswire· 2025-06-06 13:15
Core Viewpoint - Fitzroy Minerals Inc. has reported significant drilling results from the Buen Retiro Copper Project, indicating a large-scale and high-grade copper mineralization system, particularly highlighted by drill hole BRT-DDH022 which returned 110 m @ 1.94% Cu [1][2][5] Exploration and Drilling Results - The ongoing drilling program at Buen Retiro has confirmed the presence of high-grade copper mineralization, with BRT-DDH022 intersecting 110 m @ 1.94% Cu and 416 ppm Co, including 58 m @ 3.06% Cu from 97 m [5][8] - The project area covers 13,240 hectares and is located 57 km southwest of Copiapó, Chile, with a focus on near-surface copper mineralization within a 1 km-wide by 4 km-long corridor [1][3] - Phase 1 drilling was completed prior to the acquisition of Ptolemy Mining Ltd, with results documented in a technical report filed on November 8, 2024 [3] Future Plans - The company aims to drill at least 8,000 m in 2025, with a focus on the Southwest and North areas, and is considering switching to a Reverse Circulation drill rig to accelerate exploration [7][24] - Exploration efforts will continue to delineate extensions of mineralization along strike and at depth, particularly in the Southwest Area [24] Mineralization Characteristics - The mineralization in BRT-DDH022 is characterized by leachable green copper oxides, including tenorite, cuprite, and chalcocite, with significant hydrothermal alteration observed [5][10] - The presence of high-grade cuprite and chalcocite feeder structures enhances the depth potential of copper mineralization at Buen Retiro [2][15] Assay Results - The best assay results to date from the project are from hole BRT-DDH022, which intersected 110 m @ 1.94% Cu and 416 ppm Co, indicating a strong mineralization trend [8][12] - Other drill holes in the Southwest Area have shown promising intersections averaging between 0.5% to 1.9% Cu in oxides and leachable minerals from surface [15][21] Geological Context - The geology of BRT-DDH022 is described as typical of Iron-Oxide Copper Gold (IOCG) style, with significant brecciation and alteration, indicating a robust mineralizing system [10][15] - The mineralization is interpreted to be associated with a sub-vertical structure located near the center of a major magnetic anomaly [15][16]
Davis Commodities Plans to Establish Bitcoin Reserves to Strengthen Asset Allocation
GlobeNewswire· 2025-06-06 13:15
Core Insights - Davis Commodities has successfully approved a $30 million fundraising plan aimed at establishing Bitcoin reserves to enhance asset allocation and operational flexibility [1][6] - Bitcoin is recognized as a significant asset with strong value as a store of wealth, often referred to as "digital gold against inflation," and has a capped supply of 21 million coins, contributing to its desirability [2][3] - The company plans to adopt a phased accumulation strategy, allocating 15% of the fundraising amount, or $4.5 million, to acquire Bitcoin, while implementing risk management and price volatility hedging mechanisms [4][5] Company Strategy - The reserve strategy will leverage Bitcoin's non-sovereign nature and its ability to hedge against inflation, creating an asset buffer independent of traditional fiat currency systems [3][5] - By integrating Bitcoin into its asset management framework, the company aims to build a more resilient and diversified portfolio [3][6] - The management anticipates that Bitcoin's role in international trade transactions will expand as more countries integrate cryptocurrencies into their legal frameworks [5][6] Market Position - Bitcoin is currently recognized as the world's fifth-largest asset, with increasing liquidity and market maturity [2] - The successful implementation of the fundraising plan marks a significant step for Davis Commodities in diversifying its asset allocation and advancing digital transformation [6] - The company specializes in trading agricultural commodities such as sugar, rice, and oil and fat products across various markets, utilizing a global network of suppliers and logistics providers [7]
Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
GlobeNewswire· 2025-06-06 13:15
Core Insights - Apellis Pharmaceuticals and Sobi presented new data from the Phase 3 VALIANT study for EMPAVELI (pegcetacoplan) targeting C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) at the European Renal Association Congress [1][5] Study Results - EMPAVELI showed a statistically significant 68% reduction in proteinuria compared to placebo at Week 26, with effects sustained for one year [2][4] - Patients switching from placebo to EMPAVELI also experienced similar benefits in proteinuria reduction and kidney function stabilization [3] Efficacy and Safety - The study confirmed EMPAVELI's efficacy and safety profile across a diverse patient population, including adults and adolescents with both native and post-transplant kidney disease [4][7] - No new safety signals were reported, indicating favorable safety and tolerability consistent with its established profile [4][7] Clinical Significance - The results highlight the urgent need for effective treatments for patients with C3G and primary IC-MPGN, as approximately 50% of these patients may face kidney failure within five to ten years of diagnosis [6] - The VALIANT study is the largest trial conducted in these populations, involving 124 patients aged 12 and older [8] Future Prospects - Marketing applications for EMPAVELI are currently under review with the FDA and EMA, with an FDA decision expected this summer [4][7] - The collaboration between Apellis and Sobi aims to expedite the availability of EMPAVELI for patients suffering from these rare kidney diseases [10]
SuperCom Signs New Contract with Southeastern Electronic Monitoring Service Provider to Boost U.S. Market Expansion
Prnewswire· 2025-06-06 13:12
9th new service provider since mid-2024, this one to introduce SuperCom's Electronic Monitoring technology into Florida and Mississippi TEL AVIV, Israel, June 6, 2025 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, is pleased to announce it secured a new contract with an established Southeast-based service provider. The collaboration is expected to facilitate SuperCom's entrance into additional U.S. states, including Flori ...
2 Cheap Nuclear Energy Stocks to Buy Now to Ride AI-Boosted Growth
ZACKS· 2025-06-06 13:10
Key Takeaways Tech titans and the U.S. government are fully backing nuclear energy to power AI and beyond. MIR: Why this soaring under-the-radar nuclear stock is a must buy at $20 a share. Buy Nvidia-crushing Rolls-Royce for huge long-term upside in nuclear and more. Tech titans and the U.S. government—two of the biggest drivers of the economy—are fully backing nuclear energy expansion to help power economic growth and the energy-hungry artificial intelligence revolution while slowly weaning off fossil fu ...
ABM Industries (ABM) Q2 Earnings Lag Estimates
ZACKS· 2025-06-06 13:10
Core Insights - ABM Industries reported quarterly earnings of $0.86 per share, missing the Zacks Consensus Estimate of $0.87 per share, and down from $0.87 per share a year ago [1] - The company posted revenues of $2.11 billion for the quarter, exceeding the Zacks Consensus Estimate by 2.24% and up from $2.02 billion year-over-year [3] Earnings Performance - The earnings surprise for the quarter was -1.15%, while the previous quarter saw an earnings surprise of 11.54% [2] - Over the last four quarters, ABM Industries has surpassed consensus EPS estimates three times [2] Revenue Performance - ABM Industries has topped consensus revenue estimates four times over the last four quarters [3] Stock Performance - Since the beginning of the year, ABM Industries shares have increased by about 0.2%, compared to a 1% gain in the S&P 500 [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.97 on revenues of $2.16 billion, and for the current fiscal year, it is $3.76 on revenues of $8.58 billion [8] - The estimate revisions trend for ABM Industries is currently favorable, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [7] Industry Context - The Business - Services industry, to which ABM Industries belongs, is currently in the top 15% of over 250 Zacks industries, suggesting a positive outlook for stocks in this sector [9]
Unemployment Holds Steady; S&P 500 Closing In On 6000
Forbes· 2025-06-06 13:10
President Trump and Elon Musk have had a falling out in recent days. (Photo by Andrew Harnik/Getty ... More Images)Getty ImagesKey Takeaways Trump-Musk feud rattles markets; Tesla dives 14% as political tensions shake investor confidence Jobs report beats forecast slightly, but downward revisions temper enthusiasm and bond yields rise Tariffs, forecasts disappoint: Lululemon, DocuSign, Broadcom stocks fall sharply in premarket tradingMajor indices were relatively quiet on Thursday, the S&P 500 fell 0.5% and ...
First Industrial Realty: Attractive Despite Tariff Uncertainty
Seeking Alpha· 2025-06-06 13:10
Shares of First Industrial Realty Trust (NYSE: FR ) have been a modest performer over the past year, gaining just about 3%. As a major owner of logistics real estate with a significant West Coast presence, FR has meaningful exposure to tariffs, particularly onOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an art ...
Schall Law Firm Announces that it has Filed a Securities Class Action Lawsuit on Behalf of Shareholders of the Digimarc Corporation
Prnewswire· 2025-06-06 13:07
LOS ANGELES, June 6, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it has filed a class action lawsuit in the United States District Court for the District of Oregon (Portland Division), captioned Ullom v. Digimarc Corporation, et al., Case No. 3:25-cv-00779-JR, on behalf of persons and entities that purchased or otherwise acquired Digimarc Corporation ("Digimarc" or the "Company") (NASDAQ: DMRC) securities between May 3, 2024 and February 26, 2025, ...